← Back to All US Stocks

CRON Stock Analysis - Cronos Group Inc. AI Rating

CRON Nasdaq Medicinal Chemicals & Botanical Products A1 CIK: 0001656472
Recently Updated • Analysis: Mar 23, 2026 • SEC Data: 2025-12-31
AI Rating
SELL
78% Confidence

📊 CRON Key Takeaways

Revenue: $146.6M
Net Margin: -6.4%
Free Cash Flow: $149.0K
Current Ratio: 19.59x
Debt/Equity: 0.00x
EPS: $-0.02
AI Rating: SELL with 78% confidence

Investment Thesis

Cronos Group faces significant operational challenges with deteriorating profitability and negative earnings trends despite maintaining a strong balance sheet. Revenue declining 24.2% YoY combined with negative operating margins and minimal free cash flow generation suggests the company struggles to achieve sustainable profitability in its core cannabis business. While exceptional liquidity positions the company to weather near-term headwinds, the fundamental operational weakness and lack of growth momentum present material downside risk.

CRON Strengths

  • + Exceptional liquidity with $791.8M cash and 19.59x current ratio provides substantial financial flexibility
  • + Gross margin of 42.8% demonstrates viable unit economics despite operational losses
  • + Strong balance sheet with minimal debt ($0 long-term debt) eliminates financial distress risk

CRON Risks

  • ! Revenue declining 24.2% YoY indicates significant market share loss or category weakness in cannabis segment
  • ! Operating losses of $17.4M with negative net margin of -6.4% demonstrate failure to achieve profitability at scale
  • ! Minimal free cash flow generation of $149K despite $25.9M operating cash flow reveals capital intensity and working capital pressure
  • ! Net income deteriorated 222.5% YoY, signaling accelerating operational deterioration beyond top-line challenges
  • ! Negative interest coverage ratio indicates inability to service debt from operations despite current debt-free status

Key Metrics to Watch

CRON Financial Metrics

Revenue
$146.6M
Net Income
$-9.4M
EPS (Diluted)
$-0.02
Free Cash Flow
$149.0K
Total Assets
$1.2B
Cash Position
$791.8M

💡 AI Analyst Insight

The relatively thin 0.1% FCF margin may limit capital allocation flexibility. Strong liquidity with a 19.59x current ratio provides a solid financial cushion.

CRON Profitability Ratios

Gross Margin 42.8%
Operating Margin -11.9%
Net Margin -6.4%
ROE -0.9%
ROA -0.8%
FCF Margin 0.1%

CRON vs Default Sector

How Cronos Group Inc. compares to Default sector averages

Net Margin
CRON -6.4%
vs
Sector Avg 12.0%
CRON Sector
ROE
CRON -0.9%
vs
Sector Avg 15.0%
CRON Sector
Current Ratio
CRON 19.6x
vs
Sector Avg 1.8x
CRON Sector
Debt/Equity
CRON 0.0x
vs
Sector Avg 0.7x
CRON Sector

Sector benchmarks are approximate industry averages. Actual sector performance may vary.

CRON Balance Sheet & Liquidity

Current Ratio
19.59x
Quick Ratio
18.62x
Debt/Equity
0.00x
Debt/Assets
4.5%
Interest Coverage
-1,338.08x
Long-term Debt
N/A

CRON 5-Year Financial Trend

CRON 5-year financial data: Year 2021: Revenue $74.4M, Net Income $1.2B, EPS $3.33. Year 2022: Revenue $91.9M, Net Income -$73.1M, EPS N/A. Year 2023: Revenue $87.2M, Net Income -$396.1M, EPS $-1.07. Year 2024: Revenue $117.6M, Net Income -$168.7M, EPS $-0.45. Year 2025: Revenue $146.6M, Net Income -$74.0M, EPS $-0.19.
Revenue
Net Income
EPS (right axis)

5-Year Trend Summary: Cronos Group Inc.'s revenue has grown significantly by 97% over the 5-year period, indicating strong business expansion. The most recent EPS of $-0.19 indicates the company is currently unprofitable.

CRON Growth Metrics (YoY)

Revenue Growth
N/A
Year-over-year
Net Income Growth
N/A
Year-over-year
EPS Growth
N/A
Earnings per share
FCF Margin
0.1%
Free cash flow / Revenue

CRON Quarterly Performance

Quarterly financial performance data for Cronos Group Inc. including revenue, net income, and earnings per share.
Quarter Revenue Net Income EPS
Q3 2025 $34.3M -$2.6M $-0.01
Q2 2025 $27.8M -$8.8M $-0.02
Q1 2025 $25.3M -$2.2M $-0.01
Q3 2024 $24.8M -$1.6M $0.00
Q2 2024 $19.0M -$8.4M $-0.02
Q1 2024 $19.5M -$2.2M $-0.01
Q3 2023 $20.4M -$1.6M $0.00
Q2 2023 $19.0M -$8.4M $-0.02

Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.

CRON Capital Allocation

Operating Cash Flow
$25.9M
Cash generated from operations
Stock Buybacks
$9.7M
Shares repurchased (TTM)
Capital Expenditures
$25.7M
Investment in assets
Dividends
None
No dividend program

CRON SEC Filings

Access official SEC EDGAR filings for Cronos Group Inc. (CIK: 0001656472)

📋 Recent SEC Filings

Date Form Document Action
Mar 20, 2026 4 xslF345X06/wk-form4_1774041064.xml View →
Mar 17, 2026 4 xslF345X05/wk-form4_1773781956.xml View →
Mar 17, 2026 4 xslF345X05/wk-form4_1773781912.xml View →
Mar 17, 2026 4 xslF345X05/wk-form4_1773781882.xml View →
Mar 17, 2026 4 xslF345X05/wk-form4_1773781832.xml View →

Frequently Asked Questions about CRON

What is the AI rating for CRON?

Cronos Group Inc. (CRON) has an AI rating of SELL with 78% confidence, based on fundamental analysis of SEC EDGAR filings.

What are CRON's key strengths?

Exceptional liquidity with $791.8M cash and 19.59x current ratio provides substantial financial flexibility. Gross margin of 42.8% demonstrates viable unit economics despite operational losses.

What are the risks of investing in CRON?

Revenue declining 24.2% YoY indicates significant market share loss or category weakness in cannabis segment. Operating losses of $17.4M with negative net margin of -6.4% demonstrate failure to achieve profitability at scale.

What is CRON's revenue and growth?

Cronos Group Inc. reported revenue of $146.6M.

Does CRON pay dividends?

Cronos Group Inc. does not currently pay dividends.

Where can I find CRON SEC filings?

Official SEC filings for Cronos Group Inc. (CIK: 0001656472) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.

What is CRON's EPS?

Cronos Group Inc. has a diluted EPS of $-0.02.

How is the AI analysis conducted?

Our AI (Claude) analyzes publicly available SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports to evaluate financial health, profitability ratios, balance sheet strength, and growth metrics.

Disclaimer: This analysis is generated by Claude AI based on publicly available SEC EDGAR filings. It does not include stock price data and should not be considered financial advice. All fundamental data is sourced from SEC public domain filings. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.
Data Source: SEC EDGAR | Analysis Date: Mar 23, 2026 | Data as of: 2025-12-31 | Powered by Claude AI